JAMA Netw Open 2022 04 1;5(4):e228573. Epub 2022 Apr 1.
Global Value, Evidence and Outcomes, Oncology, GSK, Philadelphia, Pennsylvania.
Importance: In the United States, individuals with HIV infection have been recommended to receive a 2-dose series of the meningococcal A, C, W, Y (MenACWY) vaccine since 2016 owing to their increased risk of meningococcal disease.
Objective: To examine uptake and time to receipt of the MenACWY vaccine among people with a new diagnosis of HIV.
Design, Setting, And Participants: This cohort study used health insurance data from the US Optum Research Database from January 1, 2016, through March 31, 2018, to retrospectively identify 1208 individuals aged 2 years or older with 1 or more inpatient claim or 2 or more outpatient claims evidencing a new diagnosis of HIV infection and with continuous insurance enrollment for 12 or more months before and 6 or more months after diagnosis. Read More